Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 9/20 | 0.70 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.70 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.70 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | GMNN | O75496 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8902082 | 1.00 | ADORA1 (0.70) | ADORA1ADORA2AADORA2BADORA3MEN1 | |
| Apaxifylline SCHEMBL194806 | 0.82 | ADORA1 (1.00) | ADORA1ADORA2AADORA2BADORA3MEN1 | |
| Apaxifylline SCHEMBL194999 | 0.82 | ADORA1 (1.00) | ADORA1ADORA2AADORA2BADORA3MEN1 | |
| SCHEMBL4621677 | 0.80 | ADORA1 (1.00) | ADORA1ADORA2AADORA2BADORA3MEN1 | |
| 1,3-Dipropyl-8-Cyclopentylxanthine [Dpcpx] SCHEMBL382422 | 0.78 | ADORA1 (1.00) | ADORA1ADORA2AADORA2BADORA3MEN1 | |
| SCHEMBL4623484 | 0.77 | ADORA1 (1.00) | ADORA1ADORA2AADORA2BADORA3MEN1 | |
| SCHEMBL9729018 | 0.76 | ADORA1 (0.90) | ADORA1ADORA2AADORA2BADORA3MEN1 | |
| SCHEMBL9729354 | 0.76 | ADORA1 (0.90) | ADORA1ADORA2AADORA2BADORA3MEN1 | |
| SCHEMBL8579677 | 0.75 | ADORA1 (0.79) | ADORA1ADORA2AADORA2BADORA3MEN1 | |
| SCHEMBL8872496 | 0.74 | ADORA1 (0.83) | ADORA1ADORA2AADORA2BADORA3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5688802-A | TREATMENT OF ALZHEIMER'S DISEASE, ORGANIC BRAIN SYNDROME, PARKINSON'S DISEASE, SENILE DEMENTIA | BOEHRINGER INGELHEIM KG | 1997-11-18 | — | — | US | disclosed |
| US-5532368-A | CHOLINOMIMETIC AGENTS; ALZHEIMER*S DISEASE; CENTRAL NERVOUS SYSTEM DISORDERS | BOEHRINGER INGELHEIM GMBH (DE) | 1996-07-02 | — | — | US | disclosed |
| EP-0374808-B1 | Xanthin derivatives having an adenosin-antagonist activity | BOEHRINGER INGELHEIM KG (DE) | 1996-04-17 | — | — | EP | disclosed |
| US-5175291-A | Reaction of 1,4-dioxaspiro 4,4!nonan-7-carboxylic acid with carbonyldiimidazole with 5,6-diamino-1,3-dipropyluracil in the presence of calcium hydroxide and hydroxylating | BOEHRINGER INGELHEIM KG (DE) | 1992-12-29 | — | — | US | disclosed |
| EP-0374808-A2 | Xanthin derivatives having an adenosin-antagonist activity | BOEHRINGER INGELHEIM KG (DE) | 1990-06-27 | — | — | EP | disclosed |